Will a vaccine against the Andes virus (hantavirus) be tested in humans before the end of 2027?
AvrupaOne-OffSağlık ve Tıp1y
Manifold MarketsKYC yokDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel topluluk tahminiHayır 77.6%
Tahminciler
69
Soru türü
binary
Yöntem
Play-money forecasting platform
Kaynak türü
Tahmin
Piyasa verileri
4 saat önce güncellendi
Guncelligini yitirmis7 May 26 13:49 UTC31 Ara 27 23:59 UTC
Trendler
İlgili Piyasalar
Bağlam için ilgili sorular; eşdeğer sözleşmelerin karşılaştırması değildir.
Will Artificial wombs for premature babies be tested in humans by the end of 2026?
FutuurWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against malaria before 2028?
Manifold MarketsKurallar
Andes virus is a member of the hantavirus family responsible for the MV Hondius cruise ship outbreak.
- The only vaccine against hantaviruses in use is Hantavax which targets Hantaan river virus and Seoul virus, both "old world" hantaviruses, causing different symptoms than "new world" hantaviruses like the Andes virus (https://en.wikipedia.org/wiki/Hantavirus_vaccine)
- Moderna has been working on mRNA hantavirus vaccine, though this seems to target old world hantaviruses as well:
- https://brusselssignal.eu/2026/05/korea-university-and-moderna-have-been-working-on-mrna-hantavirus-vaccine-since-2023/
- Resolves YES if any officially sanctioned vaccine trial in humans occurs before close date, where:
- the vaccine has preclinical data suggesting possible efficacy against Andes virus
